<p>&#8220;Sana Biotechnology has shared early data for its investigational allogeneic cell therapy being studied in one patient with type 1 diabetes, sending the company’s share price up by about 200%. The data &#8216;pave the way for a potentially transformative cure,&#8217; for a disease that affects more than 1.7 million Americans, Citi analysts wrote in a [&#8230;]</p> <p>The post <a href="https://humanprogress.org/positive-results-from-islet-cell-transplantation-without-immunosuppression/">Positive Results from New Type of Islet Cell Transplantation</a> appeared first on <a href="https://humanprogress.org">Human Progress</a>.</p>